148214-90-8 Usage
General Description
(3R,4R)-tert-Butyl 3-amino-4-hydroxypyrrolidine-1-carboxylate is a chemical compound with a molecular formula C10H19NO3. It is a crystalline solid that is commonly used in organic synthesis and pharmaceutical research. (3R,4R)-tert-Butyl 3-amino-4-hydroxypyrrolidine-1-carboxylate belongs to the class of pyrrolidine carboxylates and is a derivative of tert-butyl amino acid. It has been studied for its potential medicinal properties, particularly as an inhibitor of certain enzymes and as a building block for the synthesis of pharmaceutical compounds. It has also been investigated for its potential use in the development of new drug delivery systems. Overall, (3R,4R)-tert-Butyl 3-amino-4-hydroxypyrrolidine-1-carboxylate is an important and versatile chemical compound with various potential applications in the field of chemistry and medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 148214-90-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,2,1 and 4 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 148214-90:
(8*1)+(7*4)+(6*8)+(5*2)+(4*1)+(3*4)+(2*9)+(1*0)=128
128 % 10 = 8
So 148214-90-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H18N2O3/c1-9(2,3)14-8(13)11-4-6(10)7(12)5-11/h6-7,12H,4-5,10H2,1-3H3/t6-,7-/m1/s1
148214-90-8Relevant articles and documents
Guanidine derivative and application thereof
-
Paragraph 0307; 0309-0312, (2020/06/09)
The invention relates to a guanidine derivative serving as a VAP-1 inhibitor and application of the guanidine derivative, and further relates to a pharmaceutical composition containing the compound. The compound or the pharmaceutical composition can be us
FGFR4 INHIBITOR AND PREPARATION METHOD AND USE THEREOF
-
Paragraph 0412-0413, (2019/10/10)
Provided are a class of compounds as shown in formula (I) as FGFR4 inhibitors, and pharmaceutically acceptable salts thereof, preparation methods therefor and the use thereof in the preparation of drugs for treating FGFR4-related diseases.
INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE
-
Page/Page column 157, (2018/06/30)
Compounds of formula (I') and methods of their use and preparation, as well as compositions comprising compounds of formula (I').